Provided by Tiger Trade Technology Pte. Ltd.

Quoin Pharmaceuticals

4.56
-0.3200-6.56%
Post-market: 4.560.00000.00%19:15 EDT
Volume:139.23K
Turnover:669.11K
Market Cap:9.16M
PE:-0.54
High:5.09
Open:4.88
Low:4.55
Close:4.88
52wk High:41.80
52wk Low:3.25
Shares:2.01M
Float Shares:1.83M
Volume Ratio:3.09
T/O Rate:7.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.5210
EPS(LYR):-14.7963
ROE:-575.73%
ROA:-114.60%
PB:2.33
PE(LYR):-0.31

Loading ...

Quoin Pharmaceuticals Price Target Announced at $20.00/Share by Lake Street

Dow Jones
·
Sep 23

Quoin Pharma Wins FDA Fast Track Status for Qrx003 in Peeling Skin Syndrome

Reuters
·
Sep 22

Quoin Pharmaceuticals registers to sell 9.37M ADRs for holders

TIPRANKS
·
Sep 19

Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation

TIPRANKS
·
Sep 11

Quoin Evaluates Qrx003 in Phase 2/3 Trial for Netherton Syndrome

Reuters
·
Sep 10

Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU

GlobeNewswire
·
Sep 10

Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003

TIPRANKS
·
Sep 08

Quoin Says FDA Grants Rare Pediatric Disease Designation for Qrx003 in Peeling Skin Syndrome

Reuters
·
Sep 08

Analysts’ Top Healthcare Picks: Dogwood Therapeutics (DWTX), Quoin Pharmaceuticals (QNRX)

TIPRANKS
·
Sep 04

Quoin Pharmaceuticals Director Anthony James Culverwell Acquires Shares Worth $29,988.48

Reuters
·
Sep 02

U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty

Reuters
·
Aug 28

Quoin Reports Positive Interim Phase 2/3 Data for Qrx003 in Netherton Syndrome Trial

Reuters
·
Aug 28

Quoin Pharma Prices Unregistered $50 Million Private Placement at $4.88 Per ADS

Reuters
·
Aug 28

Press Release: Quoin Pharmaceuticals Announces Private Placement Financing of up to $50.0 Million

Dow Jones
·
Aug 28

Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes

TIPRANKS
·
Aug 21

Quoin Pharmaceuticals Shareholders Approved 401(k) Matching Contribution Changes at Annual Meeting

Reuters
·
Aug 21

Quoin Pharmaceuticals reports Q2 EPS ($1.90), consensus ($1.77)

TIPRANKS
·
Aug 16

Quoin Pharmaceuticals Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Quoin Pharmaceuticals Q2 EPS $(1.90) Misses $(1.61) Estimate

Benzinga Earnings
·
Aug 14

Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 14